Aligos Therapeutics Inc (ALGS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Sales | 4,106 | 3,693 | 2,571 | 367 | 1,537 |
| Gross Profit | 4,106 | 3,693 | 2,571 | 367 | 1,537 |
| Operating Expenses | 23,054 | 24,086 | 38,128 | 38,315 | 34,605 |
| Operating Income | -18,948 | -20,393 | -35,557 | -37,948 | -33,068 |
| Other Income | 284 | 516 | -5 | 176 | 70 |
| Pre-tax Income | -18,664 | -19,877 | -35,562 | -37,772 | -32,998 |
| Income Tax | -43 | 47 | 53 | -56 | 126 |
| Net Income Continuous | -18,621 | -19,924 | -35,615 | -37,716 | -33,124 |
| Net Income | $-18,621 | $-19,924 | $-35,615 | $-37,716 | $-33,124 |
| EPS Basic Total Ops | -11.00 | -11.75 | -21.00 | -22.75 | -19.50 |
| EPS Basic Continuous Ops | -10.89 | -11.67 | -20.94 | -22.67 | -19.53 |
| EPS Diluted Total Ops | -11.00 | -11.75 | -21.00 | -22.75 | -19.50 |
| EPS Diluted Continuous Ops | -10.89 | -11.67 | -20.94 | -22.67 | -19.53 |
| EBITDA(a) | $-18,111 | $-19,528 | $-34,565 | $-36,912 | $-32,099 |